Access and quality of biomarker testing for precision oncology in Europe-Reference-Cited by-同舟云学术

Access and quality of biomarker testing for precision oncology in Europe

Published:2022-11 Issue: Volume:176 Page:70-77
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Normanno Nicola^ORCID,Apostolidis Kathi,Wolf Audrey,Al Dieri Raed^ORCID,Deans Zandra,Fairley Jenni,Maas Jörg^ORCID,Martinez Antonio^ORCID,Moch Holger,Nielsen Søren,Pilz Thomas,Rouleau Etienne^ORCID,Patton Simon,Williams Victoria

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Genomics-driven oncology: framework for an emerging paradigm;Garraway;J Clin Oncol,2013

2. The European society for medical oncology (ESMO) precision medicine glossary;Yates;Ann Oncol,2018

3. Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020;Haslam;Ann Oncol,2021

4. Cancer Biomarkers in the era of precision oncology: addressing the needs of patients and health systems;Normanno;Semin Cancer Biol,2021

5. When should we order a next generation sequencing test in a patient with cancer?;Colomer;EClinicalMedicine,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review;Value in Health;2024-09

2. From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems;Critical Reviews in Oncology/Hematology;2024-09

3. Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey;ESMO Gastrointestinal Oncology;2024-09

4. Next-generation sequencing in oncology: challenges in economic evaluations;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-11

5. EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe;European Journal of Cancer;2024-08